Edward J Despott on Muck Rack

Edward J Despott

London
As seen in: ScienceDirect, Frontline Gastroenterology, MDPI, SAGE Publishing, Texas Medical Center, Gastrointestinal Endoscopy, VideoGIE
International Advanced Endoscopy Masterclass (AEM) 5 - 7 September 2018
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Edward J

Contact Edward J, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

RISK-BENEFIT PROFILE OF COLON ESD IN THE WEST: CURATIVE RESECTION, ADVERSE EVENT, AND SURGERY RATES FROM A LARGE INTERNATIONAL MULTICENTER ANALYSIS OF 547 PATIENTS

|
By Jonathan Sanchez, Tammy Tran, Edward J Despott, Alberto Murino, Anand Kumar Verified, Jonathan Sanchez, Tammy Tran, Elisabet Maristany Bosch, Georgios Kalopitas, Kasenee Tiankanon, Saowanee Ngamruengphong, Shaimaa Elkholy, Mohamed El-Sherbiny, Karim Essam, Hany Haggag, Kevan Josloff
| Gastrointestinal Endoscopy Verified
Also available on ScienceDirect
Open in Who Shared View Duplicates (596) Issue with article?

FEASIBILITY AND EFFICACY OF ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) FOR SUPERFICIAL NEOPLASTIC LESIONS IN THE ILEOCECAL VALVE REGION: A LARGE MULTI-CENTER COMPARATIVE STUDY

|
By Mohamed O. Othman, David Diehl, Edward J Despott, Alexander Schlachterman, Kasenee Tiankanon, Joo Ha Hwang, Yasutoshi Shiratori, Manol Jovani, Anand Kumar Verified, Yutaka Tomizawa, Shaimaa Elkholy, Mohammad Bilal, Makoto Nishimura, Sayaka Nagao, Abel Joseph
| Gastrointestinal Endoscopy Verified
Table 2: Comparison of procedural duration, resection technique, resection outcomes, and adverse events in superficial colonic lesions involving the IC valve versus those not involving the IC valve.
Open in Who Shared Issue with article?

Updated review of omalizumab to treat uncontrolled pediatric allergic asthma

|
By Nikolaos Lazaridis, Edward J Despott, Debra J. Palmer, Y. Ho Shin
| ScienceDirect Verified
Section snippets Real-world data studies In children 6 to 11 years of age, the efficacy and safety of omalizumab as add-on therapy supported by randomized controlled trial (RCT) evidence have been confirmed in real-world studies (RWS) (Table I).
Open in Who Shared Issue with article?
See all 12 licensed articles (13 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified